Review



hek blue il 6 reporter line cells  (InvivoGen)


Bioz Verified Symbol InvivoGen is a verified supplier
Bioz Manufacturer Symbol InvivoGen manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    InvivoGen hek blue il 6 reporter line cells
    Hek Blue Il 6 Reporter Line Cells, supplied by InvivoGen, used in various techniques. Bioz Stars score: 95/100, based on 62 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hek+blue+il+6+reporter+line+cells/HEK-Blue+IL-6+cells/pm41145914-434-0-5
    Average 95 stars, based on 62 article reviews
    hek blue il 6 reporter line cells - by Bioz Stars, 2026-09
    95/100 stars

    Images

    Related Articles

    Activation Assay:

    Article Title: Proteolytic profiling of human plasma reveals an immunoactive complement C3 fragment.
    Article Snippet: .. HEK-Blue IL-6 reporter line cells (Invivogen #hkb-hil6) reconstituting the IL6Rα/IL6ST/STAT3 axis and exhibiting a secreted embryonic alkaline phosphatase (SEAP) response to activation were cultivated according to the manufacturer’s instructions. ..

    Article Title: Proteolytic profiling of human plasma reveals an immunoactive complement C3 fragment
    Article Snippet: .. HEK-Blue IL-6 reporter line cells (Invivogen #hkb-hil6) reconstituting the IL6Rα/IL6ST/STAT3 axis and exhibiting a secreted embryonic alkaline phosphatase (SEAP) response to activation were cultivated according to the manufacturer’s instructions. ..



    Similar Products

    hek blue il 6 reporter line cells  (InvivoGen)
    95
    InvivoGen hek blue il 6 reporter line cells
    Hek Blue Il 6 Reporter Line Cells, supplied by InvivoGen, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hek+blue+il+6+reporter+line+cells/HEK-Blue+IL-6+cells/pm41145914-434-0-5
    Average 95 stars, based on 1 article reviews
    hek blue il 6 reporter line cells - by Bioz Stars, 2026-09
    95/100 stars
    		  Buy from Supplier
    hek blue il6 reporter line  (InvivoGen)
    95
    InvivoGen hek blue il6 reporter line
    ( A ) Pull-downs with native and denatured (heat-inactivated and carbamidomethylated) C-terminally His-tagged C3-LHF1 were performed on human kidney homogenate. ( B ) Significantly enriched (BH-adj. t-test p -value < 0.05, log 2 FC > 1) proteins in the kidney pull-downs included the <t>IL6</t> signaling component IL6ST (gp130). ( C ) Thermal proteome profiling by proteome integral solubility alteration assay (TPP-PISA) in human kidney lysates to identify putative C3-LHF1 interacting proteins ( n = 3 technical replicates). Only sign. altered (BH-adj. t-test p -value < 0.05, log 2 FC > 0.58) and plasma membrane-resident proteins are displayed after addition of 1 or 10 µM C3-LHF1 (1 h, 37 °C). Proteins stabilized by interactions with C3-LHF1 display a higher abundance in the treated samples (IL6ST depicted in red). ( D ) C3-LHF1 effect on IL6R/IL6ST signaling was tested in a HEK-Blue IL6Rα/IL6ST reporter line (incubation o/N at 37 °C). C3-LHF1 effect was concentration dependent, and activating, unlike bulk C3 ( n = 4, mean ± SE; two-sided t-test p -value < 0.001 = *; IL6 used at 3 × 10 −6 µg/mL, p -value vs. untreated control: 0.0000001; p -values for 5-10-20 µM C3-LHF1 vs. untreated control: 0.000119, 0.000009, and 0.000006, respectively). ( E ) In HEK-Blue IL6Rα/IL6ST cell line with both IL6 and C3-LHF1 (o/N at 37 °C), a partial competition can be observed at IL6 concentrations of >1 × 10 −4 µg/mL ( n = 4, mean ± SE). ( F ) Tocilizumab (TOC, 2 µg/mL for 3 h at 37 °C) did not inhibit the C3-LHF1 response in the IL6Rα/IL6ST cell line, unlike the IL6 response at 1 × 10 −4 µg/mL ( n = 4, mean ± SE, two-sided t-test p -value < 0.001 = *; p -value IL6 + tocilizumab vs. IL6 at 1 × 10 −4 µg/mL = 1.5 × 10 −9 ). .
    Hek Blue Il6 Reporter Line, supplied by InvivoGen, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hek+blue+il+6+reporter+line+cells/HEK-Blue+IL-6+cells/pmc12706077-2-0-5
    Average 95 stars, based on 1 article reviews
    hek blue il6 reporter line - by Bioz Stars, 2026-09
    95/100 stars
    		  Buy from Supplier
    hek blue il 6 reporter cell line  (InvivoGen)
    95
    InvivoGen hek blue il 6 reporter cell line
    ( A ) Pull-downs with native and denatured (heat-inactivated and carbamidomethylated) C-terminally His-tagged C3-LHF1 were performed on human kidney homogenate. ( B ) Significantly enriched (BH-adj. t-test p -value < 0.05, log 2 FC > 1) proteins in the kidney pull-downs included the <t>IL6</t> signaling component IL6ST (gp130). ( C ) Thermal proteome profiling by proteome integral solubility alteration assay (TPP-PISA) in human kidney lysates to identify putative C3-LHF1 interacting proteins ( n = 3 technical replicates). Only sign. altered (BH-adj. t-test p -value < 0.05, log 2 FC > 0.58) and plasma membrane-resident proteins are displayed after addition of 1 or 10 µM C3-LHF1 (1 h, 37 °C). Proteins stabilized by interactions with C3-LHF1 display a higher abundance in the treated samples (IL6ST depicted in red). ( D ) C3-LHF1 effect on IL6R/IL6ST signaling was tested in a HEK-Blue IL6Rα/IL6ST reporter line (incubation o/N at 37 °C). C3-LHF1 effect was concentration dependent, and activating, unlike bulk C3 ( n = 4, mean ± SE; two-sided t-test p -value < 0.001 = *; IL6 used at 3 × 10 −6 µg/mL, p -value vs. untreated control: 0.0000001; p -values for 5-10-20 µM C3-LHF1 vs. untreated control: 0.000119, 0.000009, and 0.000006, respectively). ( E ) In HEK-Blue IL6Rα/IL6ST cell line with both IL6 and C3-LHF1 (o/N at 37 °C), a partial competition can be observed at IL6 concentrations of >1 × 10 −4 µg/mL ( n = 4, mean ± SE). ( F ) Tocilizumab (TOC, 2 µg/mL for 3 h at 37 °C) did not inhibit the C3-LHF1 response in the IL6Rα/IL6ST cell line, unlike the IL6 response at 1 × 10 −4 µg/mL ( n = 4, mean ± SE, two-sided t-test p -value < 0.001 = *; p -value IL6 + tocilizumab vs. IL6 at 1 × 10 −4 µg/mL = 1.5 × 10 −9 ). .
    Hek Blue Il 6 Reporter Cell Line, supplied by InvivoGen, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hek+blue+il+6+reporter+line+cells/HEK-Blue+IL-6+cells/pmc11075285-57-0-5
    Average 95 stars, based on 1 article reviews
    hek blue il 6 reporter cell line - by Bioz Stars, 2026-09
    95/100 stars
    		  Buy from Supplier
    hek bluetm il 6 reporter cell line  (InvivoGen)
    95
    InvivoGen hek bluetm il 6 reporter cell line
    ( A ) Pull-downs with native and denatured (heat-inactivated and carbamidomethylated) C-terminally His-tagged C3-LHF1 were performed on human kidney homogenate. ( B ) Significantly enriched (BH-adj. t-test p -value < 0.05, log 2 FC > 1) proteins in the kidney pull-downs included the <t>IL6</t> signaling component IL6ST (gp130). ( C ) Thermal proteome profiling by proteome integral solubility alteration assay (TPP-PISA) in human kidney lysates to identify putative C3-LHF1 interacting proteins ( n = 3 technical replicates). Only sign. altered (BH-adj. t-test p -value < 0.05, log 2 FC > 0.58) and plasma membrane-resident proteins are displayed after addition of 1 or 10 µM C3-LHF1 (1 h, 37 °C). Proteins stabilized by interactions with C3-LHF1 display a higher abundance in the treated samples (IL6ST depicted in red). ( D ) C3-LHF1 effect on IL6R/IL6ST signaling was tested in a HEK-Blue IL6Rα/IL6ST reporter line (incubation o/N at 37 °C). C3-LHF1 effect was concentration dependent, and activating, unlike bulk C3 ( n = 4, mean ± SE; two-sided t-test p -value < 0.001 = *; IL6 used at 3 × 10 −6 µg/mL, p -value vs. untreated control: 0.0000001; p -values for 5-10-20 µM C3-LHF1 vs. untreated control: 0.000119, 0.000009, and 0.000006, respectively). ( E ) In HEK-Blue IL6Rα/IL6ST cell line with both IL6 and C3-LHF1 (o/N at 37 °C), a partial competition can be observed at IL6 concentrations of >1 × 10 −4 µg/mL ( n = 4, mean ± SE). ( F ) Tocilizumab (TOC, 2 µg/mL for 3 h at 37 °C) did not inhibit the C3-LHF1 response in the IL6Rα/IL6ST cell line, unlike the IL6 response at 1 × 10 −4 µg/mL ( n = 4, mean ± SE, two-sided t-test p -value < 0.001 = *; p -value IL6 + tocilizumab vs. IL6 at 1 × 10 −4 µg/mL = 1.5 × 10 −9 ). .
    Hek Bluetm Il 6 Reporter Cell Line, supplied by InvivoGen, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hek+blue+il+6+reporter+line+cells/HEK-Blue+IL-6+cells/pm37759507-51-43-48
    Average 95 stars, based on 1 article reviews
    hek bluetm il 6 reporter cell line - by Bioz Stars, 2026-09
    95/100 stars
    		  Buy from Supplier
    il 6 reporter cell line  (InvivoGen)
    95
    InvivoGen il 6 reporter cell line
    ( A ) Pull-downs with native and denatured (heat-inactivated and carbamidomethylated) C-terminally His-tagged C3-LHF1 were performed on human kidney homogenate. ( B ) Significantly enriched (BH-adj. t-test p -value < 0.05, log 2 FC > 1) proteins in the kidney pull-downs included the <t>IL6</t> signaling component IL6ST (gp130). ( C ) Thermal proteome profiling by proteome integral solubility alteration assay (TPP-PISA) in human kidney lysates to identify putative C3-LHF1 interacting proteins ( n = 3 technical replicates). Only sign. altered (BH-adj. t-test p -value < 0.05, log 2 FC > 0.58) and plasma membrane-resident proteins are displayed after addition of 1 or 10 µM C3-LHF1 (1 h, 37 °C). Proteins stabilized by interactions with C3-LHF1 display a higher abundance in the treated samples (IL6ST depicted in red). ( D ) C3-LHF1 effect on IL6R/IL6ST signaling was tested in a HEK-Blue IL6Rα/IL6ST reporter line (incubation o/N at 37 °C). C3-LHF1 effect was concentration dependent, and activating, unlike bulk C3 ( n = 4, mean ± SE; two-sided t-test p -value < 0.001 = *; IL6 used at 3 × 10 −6 µg/mL, p -value vs. untreated control: 0.0000001; p -values for 5-10-20 µM C3-LHF1 vs. untreated control: 0.000119, 0.000009, and 0.000006, respectively). ( E ) In HEK-Blue IL6Rα/IL6ST cell line with both IL6 and C3-LHF1 (o/N at 37 °C), a partial competition can be observed at IL6 concentrations of >1 × 10 −4 µg/mL ( n = 4, mean ± SE). ( F ) Tocilizumab (TOC, 2 µg/mL for 3 h at 37 °C) did not inhibit the C3-LHF1 response in the IL6Rα/IL6ST cell line, unlike the IL6 response at 1 × 10 −4 µg/mL ( n = 4, mean ± SE, two-sided t-test p -value < 0.001 = *; p -value IL6 + tocilizumab vs. IL6 at 1 × 10 −4 µg/mL = 1.5 × 10 −9 ). .
    Il 6 Reporter Cell Line, supplied by InvivoGen, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hek+blue+il+6+reporter+line+cells/HEK-Blue+IL-6+cells/pm37759507-51-44-48
    Average 95 stars, based on 1 article reviews
    il 6 reporter cell line - by Bioz Stars, 2026-09
    95/100 stars
    		  Buy from Supplier
    reporter cell line hek blue ifn a  (InvivoGen)
    95
    InvivoGen reporter cell line hek blue ifn a
    ( A ) Pull-downs with native and denatured (heat-inactivated and carbamidomethylated) C-terminally His-tagged C3-LHF1 were performed on human kidney homogenate. ( B ) Significantly enriched (BH-adj. t-test p -value < 0.05, log 2 FC > 1) proteins in the kidney pull-downs included the <t>IL6</t> signaling component IL6ST (gp130). ( C ) Thermal proteome profiling by proteome integral solubility alteration assay (TPP-PISA) in human kidney lysates to identify putative C3-LHF1 interacting proteins ( n = 3 technical replicates). Only sign. altered (BH-adj. t-test p -value < 0.05, log 2 FC > 0.58) and plasma membrane-resident proteins are displayed after addition of 1 or 10 µM C3-LHF1 (1 h, 37 °C). Proteins stabilized by interactions with C3-LHF1 display a higher abundance in the treated samples (IL6ST depicted in red). ( D ) C3-LHF1 effect on IL6R/IL6ST signaling was tested in a HEK-Blue IL6Rα/IL6ST reporter line (incubation o/N at 37 °C). C3-LHF1 effect was concentration dependent, and activating, unlike bulk C3 ( n = 4, mean ± SE; two-sided t-test p -value < 0.001 = *; IL6 used at 3 × 10 −6 µg/mL, p -value vs. untreated control: 0.0000001; p -values for 5-10-20 µM C3-LHF1 vs. untreated control: 0.000119, 0.000009, and 0.000006, respectively). ( E ) In HEK-Blue IL6Rα/IL6ST cell line with both IL6 and C3-LHF1 (o/N at 37 °C), a partial competition can be observed at IL6 concentrations of >1 × 10 −4 µg/mL ( n = 4, mean ± SE). ( F ) Tocilizumab (TOC, 2 µg/mL for 3 h at 37 °C) did not inhibit the C3-LHF1 response in the IL6Rα/IL6ST cell line, unlike the IL6 response at 1 × 10 −4 µg/mL ( n = 4, mean ± SE, two-sided t-test p -value < 0.001 = *; p -value IL6 + tocilizumab vs. IL6 at 1 × 10 −4 µg/mL = 1.5 × 10 −9 ). .
    Reporter Cell Line Hek Blue Ifn A, supplied by InvivoGen, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hek+blue+il+6+reporter+line+cells/HEK-Blue+IL-6+cells/pm37657445-318-17-22
    Average 95 stars, based on 1 article reviews
    reporter cell line hek blue ifn a - by Bioz Stars, 2026-09
    95/100 stars
    		  Buy from Supplier

    Image Search Results


    ( A ) Pull-downs with native and denatured (heat-inactivated and carbamidomethylated) C-terminally His-tagged C3-LHF1 were performed on human kidney homogenate. ( B ) Significantly enriched (BH-adj. t-test p -value < 0.05, log 2 FC > 1) proteins in the kidney pull-downs included the IL6 signaling component IL6ST (gp130). ( C ) Thermal proteome profiling by proteome integral solubility alteration assay (TPP-PISA) in human kidney lysates to identify putative C3-LHF1 interacting proteins ( n = 3 technical replicates). Only sign. altered (BH-adj. t-test p -value < 0.05, log 2 FC > 0.58) and plasma membrane-resident proteins are displayed after addition of 1 or 10 µM C3-LHF1 (1 h, 37 °C). Proteins stabilized by interactions with C3-LHF1 display a higher abundance in the treated samples (IL6ST depicted in red). ( D ) C3-LHF1 effect on IL6R/IL6ST signaling was tested in a HEK-Blue IL6Rα/IL6ST reporter line (incubation o/N at 37 °C). C3-LHF1 effect was concentration dependent, and activating, unlike bulk C3 ( n = 4, mean ± SE; two-sided t-test p -value < 0.001 = *; IL6 used at 3 × 10 −6 µg/mL, p -value vs. untreated control: 0.0000001; p -values for 5-10-20 µM C3-LHF1 vs. untreated control: 0.000119, 0.000009, and 0.000006, respectively). ( E ) In HEK-Blue IL6Rα/IL6ST cell line with both IL6 and C3-LHF1 (o/N at 37 °C), a partial competition can be observed at IL6 concentrations of >1 × 10 −4 µg/mL ( n = 4, mean ± SE). ( F ) Tocilizumab (TOC, 2 µg/mL for 3 h at 37 °C) did not inhibit the C3-LHF1 response in the IL6Rα/IL6ST cell line, unlike the IL6 response at 1 × 10 −4 µg/mL ( n = 4, mean ± SE, two-sided t-test p -value < 0.001 = *; p -value IL6 + tocilizumab vs. IL6 at 1 × 10 −4 µg/mL = 1.5 × 10 −9 ). .

    Journal: The EMBO Journal

    Article Title: Proteolytic profiling of human plasma reveals an immunoactive complement C3 fragment

    doi: 10.1038/s44318-025-00598-8

    Figure Lengend Snippet: ( A ) Pull-downs with native and denatured (heat-inactivated and carbamidomethylated) C-terminally His-tagged C3-LHF1 were performed on human kidney homogenate. ( B ) Significantly enriched (BH-adj. t-test p -value < 0.05, log 2 FC > 1) proteins in the kidney pull-downs included the IL6 signaling component IL6ST (gp130). ( C ) Thermal proteome profiling by proteome integral solubility alteration assay (TPP-PISA) in human kidney lysates to identify putative C3-LHF1 interacting proteins ( n = 3 technical replicates). Only sign. altered (BH-adj. t-test p -value < 0.05, log 2 FC > 0.58) and plasma membrane-resident proteins are displayed after addition of 1 or 10 µM C3-LHF1 (1 h, 37 °C). Proteins stabilized by interactions with C3-LHF1 display a higher abundance in the treated samples (IL6ST depicted in red). ( D ) C3-LHF1 effect on IL6R/IL6ST signaling was tested in a HEK-Blue IL6Rα/IL6ST reporter line (incubation o/N at 37 °C). C3-LHF1 effect was concentration dependent, and activating, unlike bulk C3 ( n = 4, mean ± SE; two-sided t-test p -value < 0.001 = *; IL6 used at 3 × 10 −6 µg/mL, p -value vs. untreated control: 0.0000001; p -values for 5-10-20 µM C3-LHF1 vs. untreated control: 0.000119, 0.000009, and 0.000006, respectively). ( E ) In HEK-Blue IL6Rα/IL6ST cell line with both IL6 and C3-LHF1 (o/N at 37 °C), a partial competition can be observed at IL6 concentrations of >1 × 10 −4 µg/mL ( n = 4, mean ± SE). ( F ) Tocilizumab (TOC, 2 µg/mL for 3 h at 37 °C) did not inhibit the C3-LHF1 response in the IL6Rα/IL6ST cell line, unlike the IL6 response at 1 × 10 −4 µg/mL ( n = 4, mean ± SE, two-sided t-test p -value < 0.001 = *; p -value IL6 + tocilizumab vs. IL6 at 1 × 10 −4 µg/mL = 1.5 × 10 −9 ). .

    Article Snippet: HEK-Blue IL6 reporter line , Invivogen , #hkb-hil6.

    Techniques: Solubility, Clinical Proteomics, Membrane, Incubation, Concentration Assay, Control